Dr. Pallavi Joshi
Psychiatry (Psychiatry Physician)
1111 E Mcdowell Rd
Phoenix, AZ 85006
Who else practices at this address →
Maricopa County includes primary care (13% of residents) and dental (0% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 10
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 152
Licensed in Connecticut since 2020, according to the Connecticut Department of Public Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Psychiatry Physician primary
CT license 65592 (first issued 2020; inactive) · FL license OS19510
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Banner - University Medical Center Phoenix Phoenix, AZ
Medical groups
- Banner - University Physician Specialists LLC (348 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 152
- Services billed
- 263
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 153 | 106 |
| New patient office or other outpatient visit, 60-74 minutes | 53 | 53 |
| Established patient office or other outpatient visit, 30-39 minutes | 25 | 23 |
| Psychiatric diagnostic evaluation with medical services | 24 | 24 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Donepezil Hcl Other prescribers in Phoenix, AZ | 265 |
| Memantine Hcl Other prescribers in Phoenix, AZ | 175 |
| Escitalopram Oxalate Other prescribers in Phoenix, AZ | 142 |
| Quetiapine Fumarate Other prescribers in Phoenix, AZ | 79 |
| Rivastigmine Other prescribers in Phoenix, AZ | 59 |
| Aripiprazole Other prescribers in Phoenix, AZ | 42 |
| Fluoxetine Hcl Other prescribers in Phoenix, AZ | 40 |
| Bupropion Xl (bupropion hcl) Other prescribers in Phoenix, AZ | 38 |
| Sertraline Hcl Other prescribers in Phoenix, AZ | 37 |
| Rivastigmine (rivastigmine tartrate) Other prescribers in Phoenix, AZ | 30 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $92.66 in total to this clinician.
| Teva Pharmaceuticals USA, Inc. | $92.66 |
|---|
| Food and Beverage | $92.66 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $54,531 in research payments for these studies, mostly to the institutions running them.
- A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
E.r. Squibb & Sons, L.l.c. · Recruiting · NCT06585787 - Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
E.r. Squibb & Sons, L.l.c. · Recruiting · NCT05980949
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.